Study guide
9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging
Oregon Multistate Pharmacy Jurisprudence Examination MPJE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview & Oregon Legal Framework
1.1 Oregon MPJE Format, Fees, Blueprint & 2027 Changes 1.2 Federal–Oregon Legal Hierarchy, Agencies & the Board of Pharmacy
2 Chapter 2: Pharmacist & Pharmacist-in-Charge Responsibilities
2.1 Pharmacist Responsibilities, Supervision & Prohibited Practices 2.2 Pharmacist-in-Charge: Qualifications, Duties, Inventories & Self-Inspection
3 Chapter 3: Pharmacy Technicians, Interns & Preceptors
3.1 Pharmacy Technicians (COPT & PT): Licensure, Permitted Tasks & Limits 3.2 Pharmacy Interns & Preceptors: Licensure, Scope & Supervision
4 Chapter 4: Licensure, Renewal, Discipline & Impaired Practitioners
4.1 Pharmacist Licensure by Examination, Score Transfer & Reciprocity 4.2 License Renewal, Continuing Pharmacy Education & Lapse Rules 4.3 Grounds for Discipline, Sanctions & Mandatory Reporting Deadlines 4.4 Impaired Practitioners & the Health Professionals' Services Program (HPSP)
5 Chapter 5: Prescriber Authority & Prescription Requirements
5.1 Prescriber Authority, DEA Registration & Out-of-State Prescriptions 5.2 Non-Controlled Prescriptions: Required Elements, Signatures, Expiration & Refills 5.3 Controlled Substance Prescriptions: Schedules II–V, EPCS, Emergency Orders & Oregon's CV Limit 5.4 Drug-Use Limitations & Special Prescriptions: REMS, Death with Dignity, EPT & Standing Orders 5.5 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags
6 Chapter 6: Pharmacist Clinical Services & Prescriptive Authority
6.1 CDTM, Clinical Pharmacy Agreements, MTM & Laboratory Testing 6.2 Pharmacist Prescribing: Statewide Protocols, the Formulary & General Requirements 6.3 Pharmacist Prescribing of Hormonal Contraception (ORS 689.689) 6.4 Tobacco Cessation Protocol: Training, Screening, NRT & Non-NRT Prescribing 6.5 Vaccine Prescribing & Administration: Age Floors, Protocols, Training & ALERT IIS 6.6 Opioid Overdose Reversal & MOUD: Naloxone Prescribing, Standing Orders, Immunity & Buprenorphine
7 Chapter 7: Counseling, Language Access & Confidentiality
7.1 Patient Counseling: Triggers, Who May Offer or Accept a Refusal & Documentation 7.2 Language Access & Accessibility: Dual-Language Labels, Registry Interpreters & Prescription Readers 7.3 Patient Confidentiality: Oregon Rules, HIPAA, Part 2 & PDMP Privacy
8 Chapter 8: The Dispensing Process
8.1 Prospective Drug Utilization Review: Oregon's Eight Categories, Documentation & Who May Perform It 8.2 Oregon PDMP: Reporting Within 72 Hours, Covered Drugs, Access & Confidentiality 8.3 Prescription Transfers: Oregon's Next-Business-Day Duty & Federal Controlled Substance Limits 8.4 Dispensing Exceptions: 72-Hour Emergency Refills, Continuation of Therapy, Insulin & Declared Emergencies 8.5 Partial Fills: Schedule II (72-Hour, 30-Day CARA & 60-Day LTCF/Terminal) and Schedules III–V 8.6 Prescription Labeling: Oregon Elements, Physical Description, Expiration Dating & Med Paks 8.7 Packaging: PPPA Child-Resistant Containers, Waivers, Exemptions & Oregon's New-Container Rule 8.8 Conditions Prohibiting Dispensing, Quarantine, Returned Drugs & Charitable Reuse
9 Chapter 9: Nonprescription & Restricted Products
9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging 9.2 Dispensing-Restricted Nonprescription Products: Pseudoephedrine, Exempt Schedule V & Others
10 Chapter 10: Product Selection: Generic & Biologic Substitution
10.1 Product Selection: Generic Substitution (ORS 689.515) & Biologic Interchange (ORS 689.522)
11 Chapter 11: Acquisition, Records, Inventories & Loss Reporting
11.1 Ordering & Acquiring Controlled Substances: DEA Registration, Form 222, CSOS & the 5% Rule 11.2 Distribution Records, DSCSA, Recalls & Oregon Record Retention 11.3 Controlled Substance Inventories: Oregon's 367-Day, 93-Day, 31-Day & 15-Day Rules 11.4 Theft & Loss Reporting, Disposal, Reverse Distribution & Take-Back Receptacles
12 Chapter 12: Pharmacy Operations, Storage, Security & Special Practice Settings
12.1 Pharmacy Operations: Pharmacist Presence, Policies, Equipment, Signage, Hours & Closures 12.2 Drug Storage & Cold Chain: Temperatures, Monitoring Plans, Excursions & Vaccine Units 12.3 Security & Non-Pharmacist Access: Keys, Double Set-Ups, Institutional Night Access & DEA Controls 12.4 Hazardous Drugs: NIOSH 2024 List, USP 800 Controls, Assessment of Risk & Disposal 12.5 Compounding: OAR 855-183 (June 2026), USP 795/797/800, 503A vs. 503B & Beyond-Use Dates 12.6 Delivery of Drugs: Depots, Mail Delivery, Prescription Lockers, Kiosks & Mobile Pharmacies 12.7 Central Fill, Remote Processing, Telework & Remote Dispensing Site Pharmacies
13 Chapter 13: Drug Outlet Registration, Inspection & Institutional Practice
13.1 Drug Outlet Classes, Registration, Changes of Ownership/Location/Name & Non-Resident Pharmacies 13.2 Inspections, Self-Inspection Forms & Discipline of Drug Outlets 13.3 Institutional & Long-Term Care Practice: Drug Rooms, Night Access, E-Kits, ADCs & ED Prepacks
9.1 Nonprescription Drugs: Outlet Registration, Drug Facts Labeling & OTC Packaging
Key Takeaways Explain This Topic AI
Registered Oregon drug outlets may sell OTC drugs, but other Oregon retailers must register as nonprescription drug outlets, renewing annually by January 31.
Oregon nonprescription outlets may sell drugs only in original, unbroken, properly labeled packages and may not repackage or relabel them.
A business that only gives away OTC opioid antagonists at no cost does not have to register as an Oregon drug outlet.
The FDA Drug Facts label lists active ingredients and purpose, uses, warnings, directions, other information and inactive ingredients.
Under OAR 855-041-1020, nonprescription Schedule V products, including pseudoephedrine, must be stored in the prescription area or a secured storage area.
Last updated: October 2026
Why this matters
Area 3.8 covers the distribution and dispensing of nonprescription products, including their labeling and packaging. OTC drugs are not free of regulation. Oregon requires registration of most outlets that sell them. Federal law dictates Drug Facts labeling and tamper-evident and child-resistant packaging. Pharmacies must keep certain OTC products under pharmacist control.
Who may sell OTC drugs in Oregon
Any registered drug outlet , such as a retail pharmacy, may lawfully sell and distribute nonprescription drugs. Doing so is not improperly engaging in the practice of pharmacy (ORS 689.305(4)).
A business that sells nonprescription drugs but is not a pharmacy, such as a grocery store, convenience store or gas station, must register as a nonprescription drug outlet (ORS 689.305(2)(a)(E); OAR 855-035). Division 035 sets several registration classes:
General nonprescription outlets.
Medical gases.
Multiple vending machines (ORS 689.527 bars drug vending machines except as Board rules allow).
A no-fee class for nonprofit food-distribution facilities such as food banks.
Exemption: a business that only distributes OTC short-acting opioid antagonists at no cost does not have to register.
Nonprescription outlet registrations renew annually by January 31 (seasonal outlets have until June 1).
A store that has both a pharmacy and a front-store nonprescription registration is a double set-up . The pharmacy area must be enclosed floor to ceiling or at least 10 feet high, and posted with its hours when closed (OAR 855-041-2100).
Operating standards for nonprescription outlets (OAR 855-035)
Nonprescription outlets must:
Sell drugs only in the original, unbroken packages , properly labeled under state and federal law. No repackaging or relabeling.
Store drugs in sanitary, well-lit areas with appropriate temperature, ventilation and moisture control.
Monitor expiration dates and quarantine outdated drugs, physically separating them until they are destroyed or returned.
Never sell prescription drugs. Medical device, equipment and gas (MDEG) outlets may distribute specific prescription items, such as oxygen, under a practitioner's order, and keep records three years .
OTC labeling: Drug Facts (21 CFR 201.66)
FDA requires a standardized Drug Facts panel in this order:
Active ingredient(s) with the amount per unit, and the purpose of each.
Uses (indications).
Warnings : when not to use; when to ask a doctor or pharmacist; side effects; when to stop use; pregnancy and breastfeeding; "keep out of reach of children"; and overdose instructions.
Directions , by age group.
Other information , such as storage, and inactive ingredients .
Questions? with a phone number (optional).
A product that lacks required labeling, or carries false or misleading claims, is misbranded (FDCA 502; ORS 689.505(2)). Pharmacies that repackage OTC drugs for sale become responsible for compliant labeling. Prescription-only rules (ORS 689.505(5)) apply when an OTC drug is dispensed on a prescription , which is common for protocol-prescribed NRT or condoms. The prescription label requirements then apply.
OTC packaging
Tamper-evident packaging (21 CFR 211.132) is required for most OTC human drugs sold at retail. The label must describe the tamper-evident feature.
Child-resistant packaging (PPPA) applies to many OTC products, including aspirin, acetaminophen, iron-containing supplements, diphenhydramine, ibuprofen and naproxen. A manufacturer may market one package size without child-resistant packaging if it carries the statement "This package for households without young children" and child-resistant sizes are also available.
Products a pharmacy keeps under pharmacist or licensee control
Product Rule
Pseudoephedrine and ephedrine (Oregon Schedule V) Behind the pharmacy counter, inaccessible to the public. Sold only by a licensee with age, ID and electronic-system checks (section 9.2)
Nonprescription Schedule V controlled substances Stored within the prescription area or a secured storage area (OAR 855-041-1020(4))
Emergency contraception (levonorgestrel 1.5 mg) Federally OTC with no age limit. Oregon pharmacists may also prescribe emergency contraception under the Board protocol
Naloxone nasal spray 4 mg FDA-approved OTC (2023). Also available by pharmacist prescription or OHA standing order. Pharmacies must post notice that it is available
Pharmacist role at the OTC counter
Advice about an OTC product is counseling . A technician may not give it, because advising on therapeutic values is barred to technicians (OAR 855-125-0150), and a clerk certainly may not. A request like "What's safest with my warfarin?" belongs to the pharmacist. OTC drugs a patient uses belong in the patient record when relevant to DUR (OAR 855-041-1165(9)).
Tip
For a store selling OTC drugs without a pharmacy , the answer is a nonprescription drug outlet registration . For a registered pharmacy , OTC sales need no separate registration, unless the pharmacy runs as a double set-up with a front-store nonprescription registration.
Exam scenario
A gas station owner wants to sell ibuprofen and loratadine and to break bulk bottles into 10-tablet bags for travelers. The owner must register the station as a nonprescription drug outlet . It may sell only original, unbroken, properly labeled packages , so repackaging into bags is prohibited. The station must store the products appropriately and pull outdated stock. It may not stock pseudoephedrine, which must be kept behind a pharmacy counter and sold by a pharmacy licensee.